Amends TCA Title 20 and Title 33.
Tennessee SB0048 amends Title 20 and Title 33 of the Tennessee Code Annotated to expand the list of pharmaceutical companies whose settlement agreements related to opioid activities can be released by the attorney general, now including Amneal Pharmaceuticals, Hikma Pharmaceuticals, and Sun Pharmaceutical Industries, among others. The bill also mandates that proceeds from settlements with these companies be allocated similarly to existing opioid settlement funds, with 35% going to counties and 65% for statewide or local opioid abatement efforts. Additionally, it applies these provisions to bankruptcy plans related to opioid activities.
Tennessee SB0048 amends Title 20 and Title 33 of the Tennessee Code Annotated to expand the list of pharmaceutical companies whose settlement agreements related to opioid activities can be released by the attorney general, now including Amneal Pharmaceuticals, Hikma Pharmaceuticals, and Sun Pharmaceutical Industries, among others. The bill also mandates that proceeds from settlements with these companies be allocated similarly to existing opioid settlement funds, with 35% going to counties and 65% for statewide or local opioid abatement efforts. Additionally, it applies these provisions to bankruptcy plans related to opioid activities.
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records